ASSA ABLOY sells PKI business unit to Vista Equity Partners Share Post Post navigation Previous PostSKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026Next Post ASSA ABLOY sells PKI business unit to Vista Equity Partners